The Safety and Tolerability Study With ER2001 Intravenous Injection in Adults With Early Manifest Huntington's Disease
Clinical trial NCT06024265 · COMPLETED
Trial details
- NCT number
- NCT06024265
- Sponsor
- ExoRNA Bioscience
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-04
- Primary completion
- 2025-01-31
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.